PlainIndex

ETF comparison

PXH vs VEA

International Emerging vs International Developed.

Invesco RAFI Emerging Markets ETF · Vanguard FTSE Developed Markets Index Fund ETF Shares

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of PXH and VEA would leave roughly 0.0% of each dollar exposed to the same underlying securities.

PXH only 0.0% Shared 0.0% VEA only 0.0%
In PXH only
0 positions
Shared
0 positions
In VEA only
0 positions

Holdings data for PXH covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for VEA covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

PXH

Invesco RAFI Emerging Markets ETF

Invesco · International Emerging

61 composite / 100
Expense ratio
0.47%
Net assets
$1.95B
TTM yield
3.56%
Top-10 conc.
—
VEA

Vanguard FTSE Developed Markets Index Fund ETF Shares

Vanguard · International Developed

92 composite / 100
Expense ratio
0.030%
Net assets
$304.26B
TTM yield
2.73%
Top-10 conc.
—

Sub-score comparison

53
Cost
97
67
Tax efficiency
73
69
Liquidity
100
N/A
Concentration
N/A
—
Tracking quality
—
PXH sub-score VEA

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

VEA is 44 bps cheaper than PXH. On a $100,000 position that's about $440/yr more in fees for PXH.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in PXH

0 total

Every PXH position is also held by VEA.

Only in VEA

0 total

Every VEA position is also held by PXH.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.